SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 515 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,993 | +8.2% | 612,737 | -1.9% | 0.02% | +11.8% |
| Q2 2023 | $120,155 | -62.5% | 624,303 | -60.5% | 0.02% | -64.6% |
| Q1 2023 | $320,069 | +178.3% | 1,580,816 | +76.6% | 0.05% | +152.6% |
| Q4 2022 | $115,008 | -99.9% | 894,933 | +11.1% | 0.02% | +5.6% |
| Q3 2022 | $110,192,000 | -75.2% | 805,309 | -68.0% | 0.02% | -67.9% |
| Q2 2022 | $444,984,000 | -36.3% | 2,514,889 | -48.2% | 0.06% | -20.0% |
| Q1 2022 | $698,780,000 | -31.9% | 4,850,955 | -26.9% | 0.07% | -23.9% |
| Q4 2021 | $1,025,809,000 | -13.6% | 6,635,246 | -5.1% | 0.09% | -17.9% |
| Q3 2021 | $1,186,879,000 | +10.7% | 6,989,864 | +2.9% | 0.11% | +13.1% |
| Q2 2021 | $1,072,022,000 | +8.5% | 6,790,105 | -4.6% | 0.10% | 0.0% |
| Q1 2021 | $987,874,000 | -25.1% | 7,114,170 | -5.5% | 0.10% | -26.7% |
| Q4 2020 | $1,318,146,000 | – | 7,526,240 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |